These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 8977202)
1. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. King CL; Xianli J; Malhotra I; Liu S; Mahmoud AA; Oettgen HC J Immunol; 1997 Jan; 158(1):294-300. PubMed ID: 8977202 [TBL] [Abstract][Full Text] [Related]
2. Schistosoma mansoni: protective immunity in IL-4-deficient mice. King CL; Malhotra I; Jia X Exp Parasitol; 1996 Nov; 84(2):245-52. PubMed ID: 8932774 [TBL] [Abstract][Full Text] [Related]
3. Schistosoma mansoni infection in IgE-producing and IgE-deficient mice. El Ridi R; Ozaki T; Kamiya H J Parasitol; 1998 Feb; 84(1):171-4. PubMed ID: 9488359 [TBL] [Abstract][Full Text] [Related]
4. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice. Layland LE; Wagner H; da Costa CU Eur J Immunol; 2005 Nov; 35(11):3248-57. PubMed ID: 16276483 [TBL] [Abstract][Full Text] [Related]
5. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. Hoffmann KF; James SL; Cheever AW; Wynn TA J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689 [TBL] [Abstract][Full Text] [Related]
6. Fc epsilonRI-deficient mice infected with Schistosoma mansoni mount normal Th2-type responses while displaying enhanced liver pathology. Jankovic D; Kullberg MC; Dombrowicz D; Barbieri S; Caspar P; Wynn TA; Paul WE; Cheever AW; Kinet JP; Sher A J Immunol; 1997 Aug; 159(4):1868-75. PubMed ID: 9257851 [TBL] [Abstract][Full Text] [Related]
7. Juvenile rhesus monkeys have lower type 2 cytokine responses than adults after primary infection with Schistosoma mansoni. Fallon PG; Gibbons J; Vervenne RA; Richardson EJ; Fulford AJ; Kiarie S; Sturrock RF; Coulson PS; Deelder AM; Langermans JA; Thomas AW; Dunne DW J Infect Dis; 2003 Mar; 187(6):939-45. PubMed ID: 12660940 [TBL] [Abstract][Full Text] [Related]
8. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. Chiaramonte MG; Schopf LR; Neben TY; Cheever AW; Donaldson DD; Wynn TA J Immunol; 1999 Jan; 162(2):920-30. PubMed ID: 9916716 [TBL] [Abstract][Full Text] [Related]
9. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation. Hernandez HJ; Wang Y; Stadecker MJ J Immunol; 1997 May; 158(10):4832-7. PubMed ID: 9144498 [TBL] [Abstract][Full Text] [Related]
10. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects. James SL; DeBlois LA J Immunol; 1986 May; 136(10):3864-71. PubMed ID: 3084645 [TBL] [Abstract][Full Text] [Related]
11. Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. Fallon PG; Dunne DW J Immunol; 1999 Apr; 162(7):4122-32. PubMed ID: 10201937 [TBL] [Abstract][Full Text] [Related]
12. Role of IgE in primary murine Schistosomiasis mansoni. El Ridi R; Ragab S; Lewis S; Afifi A Scand J Immunol; 2001 Jan; 53(1):24-31. PubMed ID: 11169203 [TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Allam G Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123 [TBL] [Abstract][Full Text] [Related]
14. The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. Metwali A; Elliott D; Blum AM; Li J; Sandor M; Lynch R; Noben-Trauth N; Weinstock JV J Immunol; 1996 Nov; 157(10):4546-53. PubMed ID: 8906833 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. IV. Analysis of the role of IgE antibodies and mast cells. Sher A; Correa-Oliveira R; Hieny S; Hussain R J Immunol; 1983 Sep; 131(3):1460-5. PubMed ID: 6193190 [TBL] [Abstract][Full Text] [Related]
16. Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. II. Induction of protective immunity in experimental rat schistosomiasis. Velge-Roussel F; Auriault C; Damonneville M; Capron A J Immunol; 1991 Dec; 147(11):3967-72. PubMed ID: 1719096 [TBL] [Abstract][Full Text] [Related]
17. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. King CL; Xianli J; June CH; Abe R; Lee KP Eur J Immunol; 1996 Oct; 26(10):2448-55. PubMed ID: 8898959 [TBL] [Abstract][Full Text] [Related]
19. IgE antibody and resistance to infection. II. Effect of IgE suppression on the early and late skin reaction and resistance of rats to Schistosoma mansoni infection. Kigoni EP; Elsas PP; Lenzi HL; Dessein AJ Eur J Immunol; 1986 Jun; 16(6):589-95. PubMed ID: 3087755 [TBL] [Abstract][Full Text] [Related]
20. Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: controversial effects on the development of pathological parameters. Verwaerde C; Thiam K; Delanoye A; Fernandez-Gomez R; D'Halluin J; Auriault C Eur Cytokine Netw; 1999 Jun; 10(2):161-70. PubMed ID: 10400822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]